Combination pharmacological cardioversion of permanent atrial fibrillation in post-prosthetic mitral valve replacement outpatients: a novel approach for the treatment of atrial fibrillation.

@article{Qian2008CombinationPC,
  title={Combination pharmacological cardioversion of permanent atrial fibrillation in post-prosthetic mitral valve replacement outpatients: a novel approach for the treatment of atrial fibrillation.},
  author={Yong-jun Qian and Xiang Jian Xiao and Hui Shu Yuan and Hanbo Tang and Hezhu Shao and Dechao Wei},
  journal={The Journal of international medical research},
  year={2008},
  volume={36 3},
  pages={537-43}
}
This study explored the efficacy and safety of combination pharmacological cardioversion of permanent atrial fibrillation in outpatients following prosthetic mitral valve replacement. The study group comprised 99 outpatients who were randomly divided into two groups. In group 1 (n = 50), only ventricular heart rate was controlled. In group 2 (n = 49), combination pharmacological cardioversion therapy with low-dose oral amiodarone (2 mg/kg), captopril (0.25 mg/kg) and simvastatin (0.3 mg/kg) was… CONTINUE READING

Similar Papers

Loading similar papers…